Literature DB >> 21552196

Extreme elevation of placental alkaline phosphatase as a marker of preterm delivery, placental insufficiency and low birth weight.

Vladimír Ferianec1, Lenka Linhartová.   

Abstract

OBJECTIVE: Clinical case of extremely elevated levels of alkaline phosphatase (ALP) enzyme detected in the 3rd trimester of gestation, the diagnostic and therapeutic procedures, delivery and puerperium are presented. The paper also offers a review of the currently available bibliographical data of the issue. METHODS AND
RESULTS: The case presents a 23-year-old secundipara with clinical problems in her 3rd trimester, namely a generalized pruritus. The gestation had signs of asymmetrical fetal hypotrophy induced by placental insufficiency. Laboratory tests showed elevated (as much as a 10.5-fold increase) values of alkaline phosphatase enzyme, 94.05% of which was placental isoenzyme. The patient also had clinical symptoms of a preterm delivery. The spontaneous delivery occurred in 36 week of gestation. The postpuerperium values of alkaline phosphatase returned to normal.
CONCLUSION: The authors point out the potential relationship between elevated placental isoenzyme of alkaline phosphatase levels and placental insufficiency and the onset of a preterm delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21552196

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  5 in total

1.  Aberrant effect of genistein on placenta development expressed through alteration in transforming growth factor-β1 and alkaline phosphatase across the maternal serum, the placenta and the amniotic fluid.

Authors:  Funmileyi Olubajo Awobajo; Titilola Aderonke Samuel; Ayodele Olufemi Morakinyo; Oluwakemi Tinuolaoluwa Oyelowo; Perpetual Uzoamaka Onyekwele; Ejike Frank Medobi; Mariam Wuraola Abdul; Bilikisu Bukola Aminu; Elo Onome Oruade
Journal:  Iran J Basic Med Sci       Date:  2020-10       Impact factor: 2.699

2.  Parathyroid hormone as a marker for metabolic bone disease of prematurity.

Authors:  A Moreira; L Swischuk; M Malloy; D Mudd; C Blanco; C Geary
Journal:  J Perinatol       Date:  2014-05-29       Impact factor: 2.521

3.  Generation of monoclonal antibody MS17-57 targeting secreted alkaline phosphatase ectopically expressed on the surface of gastrointestinal cancer cells.

Authors:  Ming Li; Jianpeng Gao; Runhua Feng; Yuling Wang; Xuehua Chen; Jianyu Sun; Dongqing Zhang; Zhenggang Zhu; Lee M Ellis; Mason Lu; Jeffrey E Lee; Zhenqing Feng; Bingya Liu
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

4.  Comparisons between two biochemical markers in evaluating periodontal disease severity: a cross-sectional study.

Authors:  Sakornrat Khongkhunthian; Prachya Kongtawelert; Siriwan Ongchai; Peraphan Pothacharoen; Thanapat Sastraruji; Dhirawat Jotikasthira; Suttichai Krisanaprakornkit
Journal:  BMC Oral Health       Date:  2014-08-30       Impact factor: 2.757

Review 5.  Extracellular vesicles in normal pregnancy and pregnancy-related diseases.

Authors:  Jiayin Zhang; Haibo Li; Boyue Fan; Wenrong Xu; Xu Zhang
Journal:  J Cell Mol Med       Date:  2020-03-16       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.